Mark J. Mitton‐Fry
The Ohio State University(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Antibiotic Resistance in Bacteria, Synthesis and biological activity, Synthetic Organic Chemistry Methods, Tuberculosis Research and Epidemiology
Most-Cited Works
- → Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy(2014)239 cited
- → Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases(2018)163 cited
- → Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis(2010)128 cited
- → Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers(2010)102 cited
- → Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections(2012)97 cited
- → Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide(2012)73 cited
- → Preparation, Gram-Negative Antibacterial Activity, and Hydrolytic Stability of Novel Siderophore-Conjugated Monocarbam Diols(2011)70 cited
- → Pyridone-Conjugated Monobactam Antibiotics with Gram-Negative Activity(2013)63 cited
- → The Total Synthesis of the Oxopolyene Macrolide RK‐397(2006)60 cited
- → Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV(2013)56 cited